ACET vs ACIU

Adicet Bio, Inc. vs AC Immune SA — Valuation Comparison 2026

ACET

Biotechnology
Adicet Bio, Inc.
Quality
5.1
out of 10
Value Trap
18
SAFE
Price
$8.64
Last close
Models
9/13
Active
VS

ACIU

Biotechnology
AC Immune SA
Quality
4.5
out of 10
Value Trap
35
LOW
Price
$2.75
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType ACET Fair ValueACET Upside ACIU Fair ValueACIU Upside
Bayesian DCF Intrinsic $3.82 -55.8% $0.44 -83.8%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $1.04 -87.3% $0.09 -96.9%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ACET vs ACIU — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ACET vs ACIU — Which Stock Is More Undervalued?

ACET scores higher with a 5.1/10 quality rating vs ACIU's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Adicet Bio, Inc. (ACET) and AC Immune SA (ACIU) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ACET currently trades at $8.64 with a QOC of 5.1/10, while ACIU trades at $2.75 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).